Appropriate vascular access for patients with cancer
- PMID: 34297999
- DOI: 10.1016/S0140-6736(21)00920-X
Appropriate vascular access for patients with cancer
Comment on
-
Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.Lancet. 2021 Jul 31;398(10298):403-415. doi: 10.1016/S0140-6736(21)00766-2. Epub 2021 Jul 21. Lancet. 2021. PMID: 34297997 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
